|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.810 USD | +2.14% |
|
+24.83% | +2.32% |
| 05-14 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Journey Medical Corporation secures contract with third major GPO for Emrosi | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 3.75 | 3.75 | 4.3 |
| Spread/Res. | -0.13% | -0.13% | -12.91% |
| Spread/Supp. | +18.51% | +68.69% | +60.73% |
| Support | 3.16 | 2.22 | 2.33 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- FBIO Stock
- Charts Fortress Biotech, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
